MARTIN-IMMANUEL BITTER

Chief Executive Officer, Arctoris

Martin-Immanuel Bittner MD DPhil is the Chief Executive Officer of Arctoris, the world’s first fully automated drug discovery platform that he co-founded in 2016. He graduated as a medical doctor from the University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes scholar at the University of Oxford. Martin-Immanuel Bittner has extensive research experience covering both clinical trials and preclinical drug discovery and is an active member of several leading cancer research organisations, including EACR, AACR, and ESTRO. In recognition of his research achievements, he was elected a member of the Young Academy of the German National Academy of Sciences in 2018.

 LIVE ONLINE

20 May 2021

BOOK YOUR PLACE NOW